glp-1 side effects eyes Semaglutide Tied to Increased Risk of Serious Eye Disease GLP-1 drugs may be linked

doi: 10.1136/bmj.d6898 13 MonamiMCandidoRPintaudiBTargherGMannucciEof the SID-AMD joint panel for Italian Guidelines on Treatment of Type 2 Diabetes

The real measure of "better" isn't what happens in the first 12 weeks, but what you can sustain when life gets messy: navigating group dinners, managing changes in digestion, or accepting that the scale isn't linear

Identify patients with vagal involvement Track their symptom clusters Measure their response Separate them from other long-COVID phenotypes Without this, every study runs the risk of being written off before the true signal is even discovered

Given the low, single-digit penetration of pumps in the T2D intensive insulin therapy population, the potential impact to the insulin pump [total addressable market] looks relatively minor to us. Despite exuding positivity around GLP-1s, Hamdy sees no impact on type 1 diabetes insulin requirements

While permanent discontinuation may be appropriate in some cases, other strategies, such as dose reduction or switching to an alternative GLP-1 RA with a different pharmacokinetic profile, may help preserve the metabolic benefits of therapy while mitigating the risk of bowel obstruction

During your free consultation, our surgeons will assess your goals and provide you with a detailed cost breakdown